Solstice Capital

Solstice Capital is a venture capital firm established in 1995 and located in Salem, Massachusetts. The firm focuses on seed and early-stage investments in various sectors, including alternative energy, education, the environment, life sciences, and information technology. With a seasoned management team boasting over 90 years of combined experience in venture investing and high-growth operations, Solstice Capital is dedicated to providing not only financial support but also expert guidance to its portfolio companies as they navigate growth challenges and opportunities. The firm emphasizes positive impact investing, committing to allocate equal portions of its capital to information technology and socially responsive sectors, demonstrating its commitment to both financial returns and societal benefits.

Harry George

Co-Founder and Managing General Partner

47 past transactions

Splash Pharmaceuticals

Series D in 2018
Splash Pharmaceuticals, Inc. is a clinical stage oncology company based in San Diego, California, focused on developing innovative cancer therapies. Founded in 2001, the company is dedicated to creating novel agents that target the cell-surface glycoprotein CD44, aiming to provide significant and lasting responses in patients with various solid tumors. Its lead product, SPL-108, has shown promise in demonstrating anti-angiogenic and anti-metastatic properties, as well as enhancing the effectiveness of traditional chemotherapy agents. In addition to its oncology focus, Splash is also exploring therapies for arthritis. The company is actively seeking partnerships with pharmaceutical firms to expedite the advancement of its clinical programs.

Regenesis Biomedical

Series C in 2011
Regenesis Biomedical Inc. is a medical device company based in Scottsdale, Arizona, founded in 1996. The company specializes in the research, design, manufacture, and sale of noninvasive regenerative medicine products aimed at alleviating pain and restoring health. Its primary product, the Provant Therapy System, utilizes an electromagnetic field to reduce pain and swelling in skin and soft tissues following surgical procedures. The company serves a diverse clientele that includes healthcare facilities, acute and long-term care hospitals, skilled nursing facilities, rehabilitation centers, outpatient clinics, and home healthcare providers, all catering to patients under physician orders. Through its innovative approach, Regenesis Biomedical strives to enhance the quality of life for patients experiencing post-operative discomfort.

HTG Molecular Diagnostics

Series D in 2011
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, that specializes in precision medicine through its innovative molecular profiling technology. The company provides a range of products, including instruments, assay kits, and software, which are integrated into the HTG EdgeSeq platform. This platform automates sample processing and allows for the rapid, reliable profiling of numerous molecular targets from minimal biological samples. HTG's offerings include various molecular profiling panels designed for oncology and immuno-oncology applications, among others. The company serves a diverse clientele, including biopharmaceutical companies, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors. HTG Molecular Diagnostics has established partnerships with industry leaders to enhance its research and development efforts, further solidifying its role in advancing diagnostic applications and translational medicine. The company was founded in 1997 and was previously known as HTG, Inc. before rebranding in 2011.

HTG Molecular Diagnostics

Series C in 2008
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, that specializes in precision medicine through its innovative molecular profiling technology. The company provides a range of products, including instruments, assay kits, and software, which are integrated into the HTG EdgeSeq platform. This platform automates sample processing and allows for the rapid, reliable profiling of numerous molecular targets from minimal biological samples. HTG's offerings include various molecular profiling panels designed for oncology and immuno-oncology applications, among others. The company serves a diverse clientele, including biopharmaceutical companies, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors. HTG Molecular Diagnostics has established partnerships with industry leaders to enhance its research and development efforts, further solidifying its role in advancing diagnostic applications and translational medicine. The company was founded in 1997 and was previously known as HTG, Inc. before rebranding in 2011.

CodeRyte

Series D in 2008
CodeRyte is a leading provider of computer-assisted coding and clinical data extraction solutions tailored for the healthcare industry. The company offers advanced software that automates the coding process and efficiently analyzes physician narratives to uncover critical clinical information. Their product suite includes CodeAssist, a web-based tool that streamlines coding by integrating with operational information systems, CodeComplete, an outsourced coding solution, and DataScout, which extracts valuable clinical data from both free-text and structured medical records. CodeRyte's technology helps healthcare providers improve reimbursement accuracy, enhance compliance, and boost operational efficiency, making it a trusted partner for numerous physician practices, billing companies, and academic medical centers across the nation.

Regenesis Biomedical

Series B in 2008
Regenesis Biomedical Inc. is a medical device company based in Scottsdale, Arizona, founded in 1996. The company specializes in the research, design, manufacture, and sale of noninvasive regenerative medicine products aimed at alleviating pain and restoring health. Its primary product, the Provant Therapy System, utilizes an electromagnetic field to reduce pain and swelling in skin and soft tissues following surgical procedures. The company serves a diverse clientele that includes healthcare facilities, acute and long-term care hospitals, skilled nursing facilities, rehabilitation centers, outpatient clinics, and home healthcare providers, all catering to patients under physician orders. Through its innovative approach, Regenesis Biomedical strives to enhance the quality of life for patients experiencing post-operative discomfort.

Lumidigm

Series C in 2008
Lumidigm Inc. is a biometric technology company focused on delivering secure and reliable identification and verification solutions. The company specializes in developing identification technology that utilizes optical skin tissue measurements to produce high-quality images consistently, regardless of environmental conditions. Lumidigm's biometric identity management services are applicable across various sectors, including civil identification, point-of-sale systems, time and attendance tracking, and both physical and logical access control. Additionally, their technology extends to portable electronic device applications, ensuring that everyone is identifiable in a convenient manner.

AmpliMed Corporation

Series C in 2008
AmpliMed Corporation focuses on the development of small-molecule oncology drugs. Its products include Amplimexon, a small molecule that causes cancer cells to stop dividing and ultimately to die; Amplizone that has demonstrated efficacy in the treatment of solid tumors in animal tumor models; and benzimidazole Series: benzimidazole analog small molecules that expressed tubulin binding activity in yeast and mammalian cells. The company’s products are used to treat pancreatic cancer, lung cancer, malignant melanoma, ovarian cancer, and multiple myeloma. AmpliMed Corporation was founded in 1989 and is based in Tucson, Arizona.

HTG Molecular Diagnostics

Series C in 2007
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, that specializes in precision medicine through its innovative molecular profiling technology. The company provides a range of products, including instruments, assay kits, and software, which are integrated into the HTG EdgeSeq platform. This platform automates sample processing and allows for the rapid, reliable profiling of numerous molecular targets from minimal biological samples. HTG's offerings include various molecular profiling panels designed for oncology and immuno-oncology applications, among others. The company serves a diverse clientele, including biopharmaceutical companies, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors. HTG Molecular Diagnostics has established partnerships with industry leaders to enhance its research and development efforts, further solidifying its role in advancing diagnostic applications and translational medicine. The company was founded in 1997 and was previously known as HTG, Inc. before rebranding in 2011.

Arxan Technologies

Series C in 2007
Arxan Technologies, Inc. is a leading provider of application protection solutions, specializing in safeguarding critical applications deployed across various platforms, including mobile devices, desktops, and embedded systems in the Internet of Things (IoT). The company offers a range of services designed to protect both source and binary code, enhancing the security perimeter for organizations. Its product lineup includes GuardIT, EnsureIT, TransformIT, and Arxan for Web, which utilize advanced technologies such as code hardening, obfuscation, white-box cryptography, and threat analytics. Arxan's solutions cater to diverse sectors, including financial services, healthcare, automotive, gaming, and e-commerce, and are designed to operate without interfering with software development processes or runtime performance. In addition to its software products, the company provides professional services, including risk assessments and protection design, aimed at ensuring comprehensive security for its clients. Founded in 2001 and headquartered in San Francisco, California, Arxan Technologies has established strategic alliances with notable firms to enhance its offerings.

Regenesis Biomedical

Series B in 2006
Regenesis Biomedical Inc. is a medical device company based in Scottsdale, Arizona, founded in 1996. The company specializes in the research, design, manufacture, and sale of noninvasive regenerative medicine products aimed at alleviating pain and restoring health. Its primary product, the Provant Therapy System, utilizes an electromagnetic field to reduce pain and swelling in skin and soft tissues following surgical procedures. The company serves a diverse clientele that includes healthcare facilities, acute and long-term care hospitals, skilled nursing facilities, rehabilitation centers, outpatient clinics, and home healthcare providers, all catering to patients under physician orders. Through its innovative approach, Regenesis Biomedical strives to enhance the quality of life for patients experiencing post-operative discomfort.

PhotoThera

Series C in 2006
PhotoThera is currently hiring for the following positions: Sr. Software Engineer Mechanical Engineer Configuration Management Engineer Sr. Electrical Engineer Send your resume and cover letter to ktitano@photothera.com, or go to www.photothera.com for further information. Specialties laser, medical device, eschemic, stroke, infrared

CodeRyte

Series C in 2006
CodeRyte is a leading provider of computer-assisted coding and clinical data extraction solutions tailored for the healthcare industry. The company offers advanced software that automates the coding process and efficiently analyzes physician narratives to uncover critical clinical information. Their product suite includes CodeAssist, a web-based tool that streamlines coding by integrating with operational information systems, CodeComplete, an outsourced coding solution, and DataScout, which extracts valuable clinical data from both free-text and structured medical records. CodeRyte's technology helps healthcare providers improve reimbursement accuracy, enhance compliance, and boost operational efficiency, making it a trusted partner for numerous physician practices, billing companies, and academic medical centers across the nation.

Archivas

Series C in 2006
Archivas, Inc. specializes in developing scalable archiving software solutions that enable customers to store, protect, and manage fixed-content data efficiently in a secure online environment. Its flagship product, the Archivas Cluster (ArC), is designed to provide immediate access to archived data while reducing overall costs. The software helps organizations meet internal governance requirements and comply with external regulations, ensuring that data management practices are both effective and compliant.

E Ink

Venture Round in 2005
E Ink Corp. is a developer and supplier of electronic paper display (EPD) technologies, headquartered in Hsinchu, Taiwan. The company's innovative electronic ink products are engineered to deliver a high contrast appearance reminiscent of traditional paper while ensuring ultra-low power consumption and a lightweight design. E Ink's technology is versatile, catering to a range of consumer and industrial applications, including handheld devices, watches, clocks, and public information displays. By providing durable and energy-efficient display solutions, E Ink enables the implementation of low-power displays in a variety of settings and environments, expanding the possibilities for digital communication and information presentation.

Carefx

Series B in 2005
Carefx is a provider of information technology solutions for healthcare organizations in North America and Europe. Its primary offering, Fusionfx, is designed to bridge communication gaps between hospital and integrated delivery network leaders, as well as healthcare IT departments. Fusionfx synthesizes disparate data into clinically relevant, user-centric workflows, facilitating the connection of essential data points for patients, payers, clinicians, and compliance agencies. The suite includes interoperable workflow and analytics solutions that enhance both clinical and business operations, along with business intelligence dashboards that promote accountability and transparency within healthcare operations.

HTG Molecular Diagnostics

Series B in 2005
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, that specializes in precision medicine through its innovative molecular profiling technology. The company provides a range of products, including instruments, assay kits, and software, which are integrated into the HTG EdgeSeq platform. This platform automates sample processing and allows for the rapid, reliable profiling of numerous molecular targets from minimal biological samples. HTG's offerings include various molecular profiling panels designed for oncology and immuno-oncology applications, among others. The company serves a diverse clientele, including biopharmaceutical companies, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors. HTG Molecular Diagnostics has established partnerships with industry leaders to enhance its research and development efforts, further solidifying its role in advancing diagnostic applications and translational medicine. The company was founded in 1997 and was previously known as HTG, Inc. before rebranding in 2011.

PhotoThera

Series B in 2005
PhotoThera is currently hiring for the following positions: Sr. Software Engineer Mechanical Engineer Configuration Management Engineer Sr. Electrical Engineer Send your resume and cover letter to ktitano@photothera.com, or go to www.photothera.com for further information. Specialties laser, medical device, eschemic, stroke, infrared

Lumidigm

Series B in 2005
Lumidigm Inc. is a biometric technology company focused on delivering secure and reliable identification and verification solutions. The company specializes in developing identification technology that utilizes optical skin tissue measurements to produce high-quality images consistently, regardless of environmental conditions. Lumidigm's biometric identity management services are applicable across various sectors, including civil identification, point-of-sale systems, time and attendance tracking, and both physical and logical access control. Additionally, their technology extends to portable electronic device applications, ensuring that everyone is identifiable in a convenient manner.

Carefx

Series B in 2005
Carefx is a provider of information technology solutions for healthcare organizations in North America and Europe. Its primary offering, Fusionfx, is designed to bridge communication gaps between hospital and integrated delivery network leaders, as well as healthcare IT departments. Fusionfx synthesizes disparate data into clinically relevant, user-centric workflows, facilitating the connection of essential data points for patients, payers, clinicians, and compliance agencies. The suite includes interoperable workflow and analytics solutions that enhance both clinical and business operations, along with business intelligence dashboards that promote accountability and transparency within healthcare operations.

MetaCarta

Series C in 2005
MetaCarta specializes in geographic search and referencing solutions, enabling users to locate information related to specific locations. The company's flagship platform incorporates tools such as GeoTag, which identifies geographic references within documents. By combining geographic search and tagging functionalities, MetaCarta's technology enhances the ability to access and analyze location-based information efficiently.

AmpliMed Corporation

Series B in 2005
AmpliMed Corporation focuses on the development of small-molecule oncology drugs. Its products include Amplimexon, a small molecule that causes cancer cells to stop dividing and ultimately to die; Amplizone that has demonstrated efficacy in the treatment of solid tumors in animal tumor models; and benzimidazole Series: benzimidazole analog small molecules that expressed tubulin binding activity in yeast and mammalian cells. The company’s products are used to treat pancreatic cancer, lung cancer, malignant melanoma, ovarian cancer, and multiple myeloma. AmpliMed Corporation was founded in 1989 and is based in Tucson, Arizona.

Protonex Technology

Series C in 2005
Protonex Technology specializes in the development and manufacturing of portable fuel cell products and intelligent power management systems, catering to both military and commercial markets. The company aims to enhance energy efficiency and operational flexibility for military applications by providing mission-critical equipment. Protonex's innovative power solutions present significant advantages over traditional batteries and generators, addressing the evolving demands for portable power in various sectors.

Protonex Technology

Series B in 2005
Protonex Technology specializes in the development and manufacturing of portable fuel cell products and intelligent power management systems, catering to both military and commercial markets. The company aims to enhance energy efficiency and operational flexibility for military applications by providing mission-critical equipment. Protonex's innovative power solutions present significant advantages over traditional batteries and generators, addressing the evolving demands for portable power in various sectors.

Archivas

Series B in 2004
Archivas, Inc. specializes in developing scalable archiving software solutions that enable customers to store, protect, and manage fixed-content data efficiently in a secure online environment. Its flagship product, the Archivas Cluster (ArC), is designed to provide immediate access to archived data while reducing overall costs. The software helps organizations meet internal governance requirements and comply with external regulations, ensuring that data management practices are both effective and compliant.

StrionAir

Series B in 2004
StrionAir, Inc. is a leading manufacturer of high-performance air filtration and purification products designed to capture and eliminate airborne pathogens. The company provides both commercial and residential systems that cater to various applications, including green buildings, HVAC energy efficiency, indoor air quality, healthcare environments, and building perimeter security. StrionAir's focus on innovative air purification technology positions it as a key player in enhancing indoor air quality and promoting healthier living and working spaces.

Unveil Technologies

Venture Round in 2004
Unveil Technologies specializes in developing integrated customer self-service and agent-assist applications tailored for contact centers. The company utilizes advanced speech and language software to enhance enterprise automation systems. Its offerings include the Meaning Recognition Engine, which improves the effectiveness of speech recognition software and live agents, and the Conversation Manager Software, a platform that allows call center business analysts to create, deploy, and manage voice applications efficiently. By combining these technologies, Unveil Technologies aims to optimize communication and operational efficiency within the contact center industry.

AmpliMed Corporation

Series A in 2004
AmpliMed Corporation focuses on the development of small-molecule oncology drugs. Its products include Amplimexon, a small molecule that causes cancer cells to stop dividing and ultimately to die; Amplizone that has demonstrated efficacy in the treatment of solid tumors in animal tumor models; and benzimidazole Series: benzimidazole analog small molecules that expressed tubulin binding activity in yeast and mammalian cells. The company’s products are used to treat pancreatic cancer, lung cancer, malignant melanoma, ovarian cancer, and multiple myeloma. AmpliMed Corporation was founded in 1989 and is based in Tucson, Arizona.

Astoria Software

Series A in 2004
Astoria Software specializes in developing content management systems focused on dynamic product documentation. The company aims to simplify the creation, management, and publication of complex business-critical content by offering a comprehensive end-to-end solution. This solution encompasses authoring, content management, and rendering systems, all delivered as an integrated, on-demand service. Through its innovative approach, Astoria seeks to reduce costs and streamline processes for enterprises managing essential documentation.

E Ink

Venture Round in 2004
E Ink Corp. is a developer and supplier of electronic paper display (EPD) technologies, headquartered in Hsinchu, Taiwan. The company's innovative electronic ink products are engineered to deliver a high contrast appearance reminiscent of traditional paper while ensuring ultra-low power consumption and a lightweight design. E Ink's technology is versatile, catering to a range of consumer and industrial applications, including handheld devices, watches, clocks, and public information displays. By providing durable and energy-efficient display solutions, E Ink enables the implementation of low-power displays in a variety of settings and environments, expanding the possibilities for digital communication and information presentation.

Protonex Technology

Series A in 2004
Protonex Technology specializes in the development and manufacturing of portable fuel cell products and intelligent power management systems, catering to both military and commercial markets. The company aims to enhance energy efficiency and operational flexibility for military applications by providing mission-critical equipment. Protonex's innovative power solutions present significant advantages over traditional batteries and generators, addressing the evolving demands for portable power in various sectors.

MetaCarta

Series B in 2004
MetaCarta specializes in geographic search and referencing solutions, enabling users to locate information related to specific locations. The company's flagship platform incorporates tools such as GeoTag, which identifies geographic references within documents. By combining geographic search and tagging functionalities, MetaCarta's technology enhances the ability to access and analyze location-based information efficiently.

HTG Molecular Diagnostics

Series A in 2003
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, that specializes in precision medicine through its innovative molecular profiling technology. The company provides a range of products, including instruments, assay kits, and software, which are integrated into the HTG EdgeSeq platform. This platform automates sample processing and allows for the rapid, reliable profiling of numerous molecular targets from minimal biological samples. HTG's offerings include various molecular profiling panels designed for oncology and immuno-oncology applications, among others. The company serves a diverse clientele, including biopharmaceutical companies, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors. HTG Molecular Diagnostics has established partnerships with industry leaders to enhance its research and development efforts, further solidifying its role in advancing diagnostic applications and translational medicine. The company was founded in 1997 and was previously known as HTG, Inc. before rebranding in 2011.

AmpliMed Corporation

Series A in 2003
AmpliMed Corporation focuses on the development of small-molecule oncology drugs. Its products include Amplimexon, a small molecule that causes cancer cells to stop dividing and ultimately to die; Amplizone that has demonstrated efficacy in the treatment of solid tumors in animal tumor models; and benzimidazole Series: benzimidazole analog small molecules that expressed tubulin binding activity in yeast and mammalian cells. The company’s products are used to treat pancreatic cancer, lung cancer, malignant melanoma, ovarian cancer, and multiple myeloma. AmpliMed Corporation was founded in 1989 and is based in Tucson, Arizona.

Arxan Technologies

Series B in 2003
Arxan Technologies, Inc. is a leading provider of application protection solutions, specializing in safeguarding critical applications deployed across various platforms, including mobile devices, desktops, and embedded systems in the Internet of Things (IoT). The company offers a range of services designed to protect both source and binary code, enhancing the security perimeter for organizations. Its product lineup includes GuardIT, EnsureIT, TransformIT, and Arxan for Web, which utilize advanced technologies such as code hardening, obfuscation, white-box cryptography, and threat analytics. Arxan's solutions cater to diverse sectors, including financial services, healthcare, automotive, gaming, and e-commerce, and are designed to operate without interfering with software development processes or runtime performance. In addition to its software products, the company provides professional services, including risk assessments and protection design, aimed at ensuring comprehensive security for its clients. Founded in 2001 and headquartered in San Francisco, California, Arxan Technologies has established strategic alliances with notable firms to enhance its offerings.

Carefx

Series A in 2003
Carefx is a provider of information technology solutions for healthcare organizations in North America and Europe. Its primary offering, Fusionfx, is designed to bridge communication gaps between hospital and integrated delivery network leaders, as well as healthcare IT departments. Fusionfx synthesizes disparate data into clinically relevant, user-centric workflows, facilitating the connection of essential data points for patients, payers, clinicians, and compliance agencies. The suite includes interoperable workflow and analytics solutions that enhance both clinical and business operations, along with business intelligence dashboards that promote accountability and transparency within healthcare operations.

StrionAir

Series A in 2003
StrionAir, Inc. is a leading manufacturer of high-performance air filtration and purification products designed to capture and eliminate airborne pathogens. The company provides both commercial and residential systems that cater to various applications, including green buildings, HVAC energy efficiency, indoor air quality, healthcare environments, and building perimeter security. StrionAir's focus on innovative air purification technology positions it as a key player in enhancing indoor air quality and promoting healthier living and working spaces.

Unveil Technologies

Series A in 2003
Unveil Technologies specializes in developing integrated customer self-service and agent-assist applications tailored for contact centers. The company utilizes advanced speech and language software to enhance enterprise automation systems. Its offerings include the Meaning Recognition Engine, which improves the effectiveness of speech recognition software and live agents, and the Conversation Manager Software, a platform that allows call center business analysts to create, deploy, and manage voice applications efficiently. By combining these technologies, Unveil Technologies aims to optimize communication and operational efficiency within the contact center industry.

SupplyWorks

Venture Round in 2003
SupplyWorks is a national provider of integrated facility maintenance solutions, specializing in a comprehensive range of products and services. The company offers cleaning equipment maintenance and repair, along with a wide array of products that include janitorial supplies, plumbing and electrical tools, HVAC systems, and safety equipment. It caters to diverse sectors such as offices, educational institutions, healthcare facilities, and hospitality. SupplyWorks combines its extensive product offerings with expert services to create tailored solutions that enhance the performance, safety, and sustainability of various facilities across the United States.

Lumigent Technologies

Venture Round in 2003
Lumigent Technologies specializes in providing automated solutions for auditing and compliance reporting through its AppGRC software. This platform helps organizations manage and monitor their business applications, ensuring compliance with regulatory requirements while reducing costs and risks associated with auditing. Lumigent's offerings include features such as application risk assessment, monitoring of application activities, user management, and automated compliance reporting. Additionally, the company provides solutions for data auditing, policy management, and database assessment, helping organizations maintain the integrity of critical business information and protect against application vulnerabilities.

CellzDirect

Venture Round in 2002
CellzDirect, Inc. is a bioscience company that specializes in providing hepatocyte-based cell products and contract laboratory services primarily for the bio/pharmaceutical sector. Founded in 2002, the company is dedicated to drug metabolism and toxicology, serving a diverse clientele that includes pharmaceutical and biotechnology firms, as well as academic and governmental agencies. With facilities located in Austin, Texas, and its headquarters in Durham, North Carolina, CellzDirect focuses on supporting the testing of new drugs through its specialized cell products and services. As of January 2008, the company operates as a subsidiary of Life Technologies Corporation.

HTG Molecular Diagnostics

Series A in 2002
HTG Molecular Diagnostics is a commercial-stage life sciences company based in Tucson, Arizona, that specializes in precision medicine through its innovative molecular profiling technology. The company provides a range of products, including instruments, assay kits, and software, which are integrated into the HTG EdgeSeq platform. This platform automates sample processing and allows for the rapid, reliable profiling of numerous molecular targets from minimal biological samples. HTG's offerings include various molecular profiling panels designed for oncology and immuno-oncology applications, among others. The company serves a diverse clientele, including biopharmaceutical companies, academic research institutions, and molecular testing laboratories, distributing its products directly in the United States and Europe, as well as through international distributors. HTG Molecular Diagnostics has established partnerships with industry leaders to enhance its research and development efforts, further solidifying its role in advancing diagnostic applications and translational medicine. The company was founded in 1997 and was previously known as HTG, Inc. before rebranding in 2011.

E Ink

Venture Round in 2002
E Ink Corp. is a developer and supplier of electronic paper display (EPD) technologies, headquartered in Hsinchu, Taiwan. The company's innovative electronic ink products are engineered to deliver a high contrast appearance reminiscent of traditional paper while ensuring ultra-low power consumption and a lightweight design. E Ink's technology is versatile, catering to a range of consumer and industrial applications, including handheld devices, watches, clocks, and public information displays. By providing durable and energy-efficient display solutions, E Ink enables the implementation of low-power displays in a variety of settings and environments, expanding the possibilities for digital communication and information presentation.

Okena

Series B in 2001
Okena specializes in enterprise security software, focusing on the protection of large corporate networks. Its primary product, StormWatch, is designed to defend against various cyber threats by enforcing authorized application behavior. This approach allows businesses to engage in acceptable activities while proactively mitigating the risk of harmful actions executing within their systems. Through its application-centric technologies, Okena aims to enhance security measures and safeguard critical business operations.

Connected Corporation

Venture Round in 2001
Connected Corporation is the leading provider of storage software for automated protection, archiving and recovery of distributed data.

Sequencia

Venture Round in 2000
Sequencia offers a web-based, collaborative Product Lifecycle Management (PLM) solution known as processPoint, tailored for industries such as consumer packaged goods, food and beverage, pharmaceuticals, and specialty chemicals. In addition to its PLM capabilities, Sequencia provides supply chain management services and has developed an enterprise resource planning platform that enhances vendor management. This integrated approach supports businesses in efficiently managing their product development and supply chain processes.

I2 Technologies

Seed Round in 1996
I2 Technologies is a full-service supply chain management company that specializes in providing consulting, technology, and managed services. The company focuses on building successful partnerships with its clients, helping them achieve optimal business results. I2's solutions cater to a diverse range of industries, positioning the company as a key player in the supply chain sector. Through its comprehensive offerings, I2 Technologies aims to enhance operational efficiency and drive growth for its customers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.